Baseline subendocardial viability ratio influences left ventricular systolic improvement with cardiac rehabilitation
1Department of Cardiology, Yeditepe University Hospital; İstanbul-Turkey
2Department of Cardiology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP); Paris-France
3Department of Cardiology, UMR-S 942, Université Paris Diderot, DHU FIRE, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP); Paris-France
Anatol J Cardiol 2017; 1(17): 37-43 PubMed ID: 27443478 PMCID: 5324860 DOI: 10.14744/AnatolJCardiol.2016.7009
Full Text PDF

Abstract

Objective: Subendocardial viability ratio (SEVR), defined as diastolic to systolic pressure-time integral ratio, is a useful tool reflecting the balance between coronary perfusion and arterial load. Suboptimal SEVR creating a supply–demand imbalance may limit favorable cardiac response to cardiac rehabilitation (CR). To explore this hypothesis, we designed a study to analyze the relationship between baseline SEVR and response to CR in patients with coronary artery disease (CAD).
Materials and Methods: In this prospectively study, after baseline arterial tonometry, echocardiography, and cardiopulmonary exercise tests (CPETs), patients undergone 20 sessions of CR. Post-CR echocardiographic and CPET measurements were obtained for comparison.
Results: Final study population was comprised of fifty subjects. Study population was divided into two subgroups by median SEVR value (1.45, interquartile range 0.38). Although both groups showed significant improvements in peak VO2, significant improvements in oxygen pulse (πO2) (from 16.1±3.4 to 19.1±4.8 mL O2.kg–1.beat–1; p<0.001) and stroke volume index (from 31±5 to 35±6 mL; p=0.008) were observed in only the patients in the above-median subgroup. The change in πO2 was also significantly higher in the above-median SEVR subgroup (2.9±3.3 vs. 0.5±2.4; p=0.007).
Conclusion: Our study shows that baseline supply–demand imbalance may limit systolic improvement response to CR in patients with CAD. (Anatol J Cardiol 2017; 17: 37-43)